Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine
- PMID: 28338977
- PMCID: PMC5581900
- DOI: 10.1093/schbul/sbw193
Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine
Abstract
Cognitive deficits in schizophrenia have been hypothesized to reflect N-methyl-D-aspartate receptor (NMDAR) dysfunction. However, the mechanisms through which the NMDAR contributes to individual cognitive functions differ. To explore how NMDAR signaling relates to specific cognitive deficits in schizophrenia, we tested the effects of enhancing NMDAR signaling on working memory and experience-dependent plasticity using d-cycloserine (DCS). Plasticity was assessed using an EEG paradigm that utilizes high-frequency visual stimulation (HFvS) to induce neural potentiation, and 2 learning tasks, the information integration (IIT) and weather prediction (WPT) tasks. Working memory was assessed using an N-back task. Forty-five schizophrenia patients were randomized to receive a single 100 mg DCS dose (SZ-DCS; n = 24) or placebo (SZ-PLC; n = 21) in a double-blind, between-groups design. Testing occurred on a single day after placebo or DCS administration; baseline values were not obtained. DCS did not affect plasticity, as indicated by similar neural potentiation, and similar IIT and WPT learning between groups. However, among patients who successfully engaged in the working memory task (ie, performed above chance), SZ-DCS (n = 17) showed superior 2-back performance compared to SZ-PLC (n = 16). Interestingly, SZ-DCS also showed larger pre-HFvS neural responses during the LTP task. Notably, this pattern of DCS effects is the opposite of those found in our prior study of healthy adults. Results are consistent with target engagement of the NMDAR by DCS, but suggest that NMDAR signaling was not translated into synaptic plasticity changes in schizophrenia. Results highlight the importance of considering how distinct NMDAR-associated processes contribute to individual cognitive deficits in schizophrenia.
Keywords: NMDA receptor; cognition; learning; long-term potentiation; memory; psychosis.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures




Similar articles
-
Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain.Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15331-6. doi: 10.1073/pnas.1509262112. Epub 2015 Nov 30. Proc Natl Acad Sci U S A. 2015. PMID: 26621715 Free PMC article. Clinical Trial.
-
Altered neural oscillations are associated with improved working memory performance in schizophrenia following D-cycloserine administration.Schizophr Res. 2025 Aug;282:85-94. doi: 10.1016/j.schres.2025.06.001. Epub 2025 Jun 13. Schizophr Res. 2025. PMID: 40513304 Clinical Trial.
-
An N-methyl-D-aspartate receptor agonist facilitates sleep-independent synaptic plasticity associated with working memory capacity enhancement.Sci Rep. 2011;1:127. doi: 10.1038/srep00127. Epub 2011 Oct 24. Sci Rep. 2011. PMID: 22355644 Free PMC article. Clinical Trial.
-
D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.Schizophr Bull. 2012 Sep;38(5):936-41. doi: 10.1093/schbul/sbs012. Epub 2012 Feb 23. Schizophr Bull. 2012. PMID: 22368237 Free PMC article. Review.
-
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.Curr Neuropharmacol. 2017;15(1):21-34. doi: 10.2174/1570159x14666160225154812. Curr Neuropharmacol. 2017. PMID: 26915421 Free PMC article. Review.
Cited by
-
Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia.Front Neurosci. 2021 Apr 12;15:641047. doi: 10.3389/fnins.2021.641047. eCollection 2021. Front Neurosci. 2021. PMID: 33912003 Free PMC article. Review.
-
Loosening of Associations in Chronic Schizophrenia: Intersectionality of Verbal Learning, Negative Symptoms, and Brain Structure.Schizophr Bull Open. 2022 Mar 8;3(1):sgac004. doi: 10.1093/schizbullopen/sgac004. eCollection 2022 Jan. Schizophr Bull Open. 2022. PMID: 35295655 Free PMC article.
-
Efficacy of adjunctive D-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.J Neural Transm (Vienna). 2021 Feb;128(2):253-262. doi: 10.1007/s00702-020-02292-x. Epub 2021 Jan 13. J Neural Transm (Vienna). 2021. PMID: 33439362
-
Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jul;3(7):581-590. doi: 10.1016/j.bpsc.2018.02.002. Epub 2018 Feb 22. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29656951 Free PMC article. Review.
-
Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.Schizophr Res. 2021 Apr;230:26-37. doi: 10.1016/j.schres.2021.01.028. Epub 2021 Mar 2. Schizophr Res. 2021. PMID: 33667856 Free PMC article.
References
-
- Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull. 1999;25:309–319. - PubMed
-
- Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41–51. - PubMed
-
- Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry. 2001;58:24–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases